Aprogen Medicines Inc announced a private placement of 5,000,000 common shares of par value KRW 500 at discount of 8.2% of KRW 1,100 per share for gross proceeds of KRW 5,500,000,000 on October 13, 2023. The common shares have a lock up period of 1 year. The transaction has been approved by the board of directors of the company.

The shares are issued through a third party allotment method.